Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005974-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R183Q	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: yes	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.824	Missense_Mutation	SNP	Diploid	44	SOMATIC	NA	MSKCC	19	52715983	52715983	G	A	19:g.52715983G>A	ENST00000322088.6:c.548G>A							5	5/15		Likely_pathogenic	rs1057519947			52		YES		0.2988						LUAD				1	Female	Never		Matched	4.89359848807			NO	EGFR	IMPACT410	NO	MSKCC	3		Adenocarcinoma	Lung	YES	Tumor	818	NO	Primary		IV	YES	YES	60	DOD																													
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s18	Lung cancer	Lung Adenocarcinoma	K546*	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP			NA	NA	MSKCC	19	52725469	52725469	A	T	19:g.52725469A>T	ENST00000322088.6:c.1636A>T	0.11		7	58			752	13/15								Durable Clinical Benefit			Non-Squamous			727		LUAD		29.7331		1	Female			Matched	25.4																												0:Censor					69	PR	1	A*02:01	A*02:01	B*40:01	B*44:02	C*03:04	C*07:04	3.0	1858	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004114-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X554_splice	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	19	52728969	52728969	G	T	19:g.52728969G>T	ENST00000322088.6:c.1662-1G>T							45							47				0.1172						LUAD				1	Male	Former heavy		Matched	44.0423863927			NO	UNKNOWN DRIVER	IMPACT410	YES	MSKCC	2		Adenocarcinoma	Lung	YES	Tumor	685	NO	Primary	Note: The BCL2L1 and CRKL copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	NO	YES		DOD																													
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0010715-T01-IM5	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	W140R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: yes	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.619	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	19	52714660	52714660	T	A	19:g.52714660T>A	ENST00000322088.6:c.418T>A	0.09		127	1248		325	51	4/15						67		NE		0.5186						LUNE		2.77		1	Male			Matched	49.9147045784					IMPACT410																							0:Not Progressed																	0.52	Commercial	2	48.11320755		Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0014172-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R134L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: yes	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.524	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	19	52714643	52714643	G	T	19:g.52714643G>T	ENST00000322088.6:c.401G>T	0.35		114	212		533	19	4/15						83		NO		0.2699						LUAD		3.77		1	Male			Matched	17.6169545571					IMPACT410																							1:Progressed																	0.27	Commercial	1	16.98113208	25	Ever	Monotherapy
Lung Adenocarcinoma (MSKCC, Science 2015)	BL3403	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S122F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.093	Missense_Mutation	SNP			NA	NA	NA	19	52714607	52714607	C	T	19:g.52714607C>T	ENST00000322088.6:c.365C>T	0.14		25	160		156	143	4/15			rs11537698		2	73	Pembrolizumab (Dose 10 mg/kg)	No durable benefit	Progression-free Survival	0.7476	Adenocarcinoma	Transversion Low	99	148	Self reported self status	LUAD	Weak(1-49% membraneous staining	6.5	1	1	Female	Former	43.75	Matched	4.73333333333	261	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D176H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.98	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	19	52715961	52715961	G	C	19:g.52715961G>C	ENST00000322088.6:c.526G>C	0.29		395	955		502	90	5/15						53		YES		0.5235						LUAD		13.17		1	Male			Matched	96.496511152					IMPACT341																							1:Progressed																	0.52	Commercial	2	91.83673469		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009293-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V274L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.19;Polyphen-2: impact: benign, score: 0.001	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	19	52719044	52719044	G	T	19:g.52719044G>T	ENST00000322088.6:c.820G>T	0.32	0.0064	253	548	2	312	22	7/15						80		YES		0.1590						LUAD		16.57		1	Female			Matched	21.5318333475					IMPACT410																							0:Not Progressed																	0.16	Commercial	2	20.75471698	0	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009764-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L55R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.943	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	19	52705282	52705282	T	G	19:g.52705282T>G	ENST00000322088.6:c.164T>G	0.08		59	665		631	23	2/15						50		YES		0.2026						LUAD		6.3		1	Female			Matched	22.5105530451					IMPACT410																							0:Not Progressed																	0.2	Commercial	2	21.69811321		Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002459-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R28L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.981	Missense_Mutation	SNP	Diploid	3	SOMATIC	NA	MSKCC	19	52705201	52705201	G	T	19:g.52705201G>T	ENST00000322088.6:c.83G>T							22	2/15						62				0.5407						LUAD				1	Female	Former heavy		Matched	24.4014166131			NO	KRAS	IMPACT341	NO	MSKCC	0	Pleura	Adenocarcinoma	Lung	YES	Tumor	593	YES	Metastasis		IV	NO	YES		DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004687-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R46K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.021	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	19	52705255	52705255	G	A	19:g.52705255G>A	ENST00000322088.6:c.137G>A							32	2/15						82				0.0191						LUAD				1	Female	Former heavy		Matched	30.3403106261			NO	KRAS	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	502	YES	Primary	Note: The JAK2 and CD274 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	NO	NO	20	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000627-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Y155N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.995	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	19	52714705	52714705	T	A	19:g.52714705T>A	ENST00000322088.6:c.463T>A							21	4/15						60				0.1023						LUAD				1	Female	Former heavy		Matched	23.2922613126			NO	NF1_truncating	IMPACT341	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	753	NO	Metastasis		IB	NO	YES	35	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002016-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I206V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.3;Polyphen-2: impact: benign, score: 0	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52716051	52716051	A	G	19:g.52716051A>G	ENST00000322088.6:c.616A>G							23	5/15						71				0.3955						LUAD				1	Male	Former heavy		Matched	25.5105719137			NO	CDKN2A loss	IMPACT341	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	331	YES	Primary		IV	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001131-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A461V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.628	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52724250	52724250	C	T	19:g.52724250C>T	ENST00000322088.6:c.1382C>T							8	12/15						59		YES		0.1293						LUAD				1	Female	Former heavy		Matched	8.87324240478			NO	EGFR	IMPACT341	NO	MSKCC	0	Uterus	Adenocarcinoma	Lung	YES	Tumor	1038	YES	Metastasis		IV	YES	NO	25	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003165-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E191K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.73;Polyphen-2: impact: benign, score: 0.065	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52716006	52716006	G	A	19:g.52716006G>A	ENST00000322088.6:c.571G>A							24	5/15						42				0.5215						LUAD				1	Female	Former light		Matched	23.4892727428			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	2	Liver	Adenocarcinoma	Lung	YES	Tumor	745	NO	Metastasis	Note: Copy number profile is suggestive of copy number loss on Chromosome arm 9p21-24.	IIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D176H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.98	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52715961	52715961	G	C	19:g.52715961G>C	ENST00000322088.6:c.526G>C							90	5/15						51				0.5235						LUAD				1	Male	Former heavy		Matched	96.496511152			YES	PIK3CA	IMPACT341	YES	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	1189	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006979-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	P276T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.09;Polyphen-2: impact: benign, score: 0.003	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52719050	52719050	C	A	19:g.52719050C>A	ENST00000322088.6:c.826C>A							21	7/15	0.00000401952	Uncertain_significance	rs777655260			54				0.1211						LUAD				1	Male	Former heavy		Matched	20.5531136499			NO	ERBB2_WT_AMP	IMPACT410	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	836	NO	Primary	Note: The ERBB2 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory FISH is suggested, if clinically indicated.	IV	NO	NO	40	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009293-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V274L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.19;Polyphen-2: impact: benign, score: 0.001	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52719044	52719044	G	T	19:g.52719044G>T	ENST00000322088.6:c.820G>T							22	7/15						69				0.1590						LUAD				1	Female	Former heavy		Matched	21.5318333475			YES	BRAF non-V600	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	558	NO	Metastasis		IIIA	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009764-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L55R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.943	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	52705282	52705282	T	G	19:g.52705282T>G	ENST00000322088.6:c.164T>G							23	2/15						50				0.2026						LUAD				1	Female	Former heavy		Matched	22.5105530451			NO	EGFR_WT_AMP	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	893	YES	Primary		IV	NO	YES	40	AWD																													
Non-small cell lung cancer (MSK, Science 2015)	BL3403	Lung cancer	Lung Adenocarcinoma	S122F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.093	Missense_Mutation	SNP			Somatic	NA	MSKCC	19	52714607	52714607	C	T	19:g.52714607C>T	ENST00000322088.6:c.365C>T							143	4/15			rs11537698					NDB			Adenocarcinoma	Transversion Low	99	148		LUAD	Weak	6.5	1	1	Female	Former		Matched	4.7	261												Tumor			Met							73	10	142.309651	178.814652	Stable Response	1:Event	FFPE	43.75	Pleura	2																			
